News
HC Wainwright & Co. Reiterates Buy on Oculis Holding, Maintains $28 Price Target
30 May 24
News, Price Target, Reiteration, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Oculis Holding, Maintains $28 Price Target
13 May 24
News, Price Target, Reiteration, Analyst Ratings
Oculis Holding Q1 EPS $(0.50) Misses $(0.41) Estimate, Sales $254.06K Miss $280.00K Estimate
8 May 24
Earnings, Earnings Misses, News
Oculis Announces Completion Of Enrollment In Phase 2 Randomized Controlled ACUITY Trial With OCS-05 For Acute Optic Neuritis
8 May 24
Biotech, News, General
Chardan Capital Maintains Buy on Oculis Holding, Maintains $30 Price Target
19 Mar 24
News, Price Target, Analyst Ratings
Baird Maintains Outperform on Oculis Holding, Lowers Price Target to $35
19 Mar 24
News, Price Target, Analyst Ratings
Press releases
Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board
30 May 24
News, Management, Press Releases
Oculis Reports Q1 2024 Financial Results and Provides Company Updates
8 May 24
Earnings, Health Care, Press Releases
Oculis to Present at Bank of America Global Healthcare Conference
6 May 24
News, Health Care, Press Releases
Oculis to Participate at Upcoming April Investor Conferences
4 Apr 24
News, Press Releases
Oculis Reports Q4 and Full Year 2023 Financial Results and Update on Company Progress
18 Mar 24
Earnings, Press Releases